Literature DB >> 1140846

Platelet kinetics in canine ehrlichiosis: evidence for increased platelet destruction as the cause of thrombocytopenia.

R D Smith, M Ristic, D L Huxsoll, R A Baylor.   

Abstract

A significant (P < 0.025) increase in the mean platelet diameter occurred in five Ehrlichia canis-infected dogs when platelet numbers decreased to 100,000/mul or less. Maximal incorporation of [(75)Se]selenomethionine into platelets of six uninfected dogs was 0.080 +/- 0.019% (mean +/- standard error) and occurred 5 to 6 days after dosage, whereas maximal incorporation was 0.036 +/- 0.004% within 2 to 3 days after dosage in seven chronically infected dogs that had thrombocytopenia. Analysis of the [(75)Se]selenomethionine curves yielded a platelet lifespan of 9 days in uninfected dogs versus 4 days in chronically infected dogs. Thus, megakaryocyte maturation and/or platelet release occurred at an accelerated rate in infected dogs, whereas increased destruction of newly produced labeled platelets diminished their number of peripheral blood. [(51)Cr]sodium chromate-labeled platelet survival was exponential, with a half-life of approximately 1 day in two dogs at 2 to 4 days postinfection and three chronically infected dogs. Platelet survival time was 8 days and rectilinear in four uninfected dogs. Platelet recovery was 39.43 +/- 2.86% in infected dogs as compared with 68.2 +/- 10.72% in uninfected dogs. Whole-body scans of one dog prior to and 7 days after infection showed that labeled platelets were destroyed primarily in the spleen. It is concluded that the thrombocytopenia in E. canis-infected dogs is the result of increased platelet destruction which begins within a few days after infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1140846      PMCID: PMC415202          DOI: 10.1128/iai.11.6.1216-1221.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Life span of thrombocytes and erythrocytes in normal and thrombocytopenic calves.

Authors:  N S MIZUNO; V PERMAN; F W BATES; J H SAUTTER; M O SCHULTZE
Journal:  Blood       Date:  1959-06       Impact factor: 22.113

2.  Pathology of canine ehrlichiosis (tropical canine pancytopenia).

Authors:  P K Hildebrandt; D L Huxsoll; J S Walker; R M Nims; R Taylor; M Andrews
Journal:  Am J Vet Res       Date:  1973-10       Impact factor: 1.156

3.  Radioisotopic blood volume and cardiac output in dogs.

Authors:  M H Lombardi
Journal:  Am J Vet Res       Date:  1972-09       Impact factor: 1.156

4.  Biochemical and clinical aspects of megathrombocytes.

Authors:  S Karpatkin
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

5.  (51Cr)platelet kinetics in thrombocytopenia. Correlation between splenic sequestration of platelets and response to splenectomy.

Authors:  C A Ries; D C Price
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

6.  The new national health spending policy.

Authors:  R Fein
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

7.  Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP).

Authors:  I Branehög; J Kutti; A Weinfeld
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

Review 8.  The megathrombocyte as an index of platelet production.

Authors:  S Karpatkin; S K Garg
Journal:  Br J Haematol       Date:  1974-03       Impact factor: 6.998

9.  Relationship of Ehrlichia canis-infected mononuclear cells to blood vessels of lungs.

Authors:  C F Simpson
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

10.  Tropical canine pancytopenia: Clinical, hematologic, and serologic response of dogs to Ehrlichia canis infection, tetracycline therapy, and challenge inoculation.

Authors:  W C Buhles; D L Huxsoll; M Ristic
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

View more
  8 in total

Review 1.  Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis.

Authors:  S Harrus; T Waner; H Bark; F Jongejan; A W Cornelissen
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Evaluation of clinical, biochemical and haematological markers in natural infection of canine monocytic ehrlichiosis.

Authors:  Rahul Parashar; Vikrant Sudan; Amit Kumar Jaiswal; Ashish Srivastava; Daya Shanker
Journal:  J Parasit Dis       Date:  2015-05-08

3.  Laboratory findings in cows after experimental infection with Ehrlichia phagocytophila.

Authors:  N Pusterla; J Huder; C Wolfensberger; U Braun; H Lutz
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

4.  Platelet migration inhibtion as an indicator of immunologically mediated target cell injury in canine ehrlichiosis.

Authors:  I Kakoma; C A Carson; M Ristic; E M Stephenson; P K Hildebrandt; D L Huxsoll
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

5.  Cytoplasmic, nuclear, and platelet autoantibodies in human granulocytic ehrlichiosis patients.

Authors:  S J Wong; J A Thomas
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

6.  Hematological changes as prognostic indicators of survival: similarities between Gottingen minipigs, humans, and other large animal models.

Authors:  Maria Moroni; Eric Lombardini; Rudolph Salber; Mehdi Kazemzedeh; Vitaly Nagy; Cara Olsen; Mark H Whitnall
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

7.  Retrospective analysis of canine monocytic ehrlichiosis in Thailand with emphasis on hematological and ultrasonographic changes.

Authors:  Kris Angkanaporn; Jidapha Sanguanwai; Taratip O Baiyokvichit; Pichamon Vorrachotvarittorn; Montana Wongsompong; Woraporn Sukhumavasi
Journal:  Vet World       Date:  2022-01-05

Review 8.  Epidemiological and Clinicopathological Features of Anaplasma phagocytophilum Infection in Dogs: A Systematic Review.

Authors:  Sarah El Hamiani Khatat; Sylvie Daminet; Luc Duchateau; Latifa Elhachimi; Malika Kachani; Hamid Sahibi
Journal:  Front Vet Sci       Date:  2021-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.